Computational studies of anaplastic lymphoma kinase mutations reveal common mechanisms of oncogenic activation.

作者: Yaël P Mossé , Mark A Lemmon , Ravi Radhakrishnan , Jin H Park , Jin H Park

DOI: 10.1073/PNAS.2019132118

关键词: Computational biologyProtein kinase domainAnaplastic lymphoma kinaseKinaseTarget proteinCancerAmino acidMutationDiseaseBiology

摘要: Kinases play important roles in diverse cellular processes, including signaling, differentiation, proliferation, and metabolism. They are frequently mutated cancer the targets of a large number specific inhibitors. Surveys genome atlases reveal that kinase domains, which consist 300 amino acids, can harbor numerous (150 to 200) single-point mutations across different patients same disease. This preponderance mutations-some activating, some silent-in known target protein make clinical decisions for enrolling drug trials challenging since relevance its sensitivity often depend on mutational status given patient. We show through computational studies using molecular dynamics (MD) as well enhanced sampling simulations experimentally determined activation be predicted effectively by identifying hydrogen bonding fingerprint loop αC-helix regions, despite fact occur throughout domain. In our study, we find predictive power MD is superior purely data-driven machine learning model involving biochemical features implemented, even though utilized far fewer (in fact, just one) an unsupervised setting. Moreover, results provide key insights into convergent mechanisms activation, primarily differential stabilization bond network engages residues active-like conformation >70% studied, regardless location mutation).

参考文章(73)
Chris Greenman, Richard Wooster, P. Andrew Futreal, Michael R. Stratton, Douglas F. Easton, Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics. ,vol. 173, pp. 2187- 2198 ,(2006) , 10.1534/GENETICS.105.044677
Jack Kyte, Russell F. Doolittle, A simple method for displaying the hydropathic character of a protein Journal of Molecular Biology. ,vol. 157, pp. 105- 132 ,(1982) , 10.1016/0022-2836(82)90515-0
Diwakar Shukla, Yilin Meng, Benoît Roux, Vijay S. Pande, Activation pathway of Src kinase reveals intermediate states as targets for drug design Nature Communications. ,vol. 5, pp. 3397- 3397 ,(2014) , 10.1038/NCOMMS4397
Daniel A. Haber, Jeff Settleman, Cancer: drivers and passengers. Nature. ,vol. 446, pp. 145- 146 ,(2007) , 10.1038/446145A
Joshua S. Kaminker, Yan Zhang, Allison Waugh, Peter M. Haverty, Brock Peters, Dragan Sebisanovic, Jeremy Stinson, William F. Forrest, J. Fernando Bazan, Somasekar Seshagiri, Zemin Zhang, Distinguishing cancer-associated missense mutations from common polymorphisms. Cancer Research. ,vol. 67, pp. 465- 473 ,(2007) , 10.1158/0008-5472.CAN-06-1736
Morgan Huse, John Kuriyan, The Conformational Plasticity of Protein Kinases Cell. ,vol. 109, pp. 275- 282 ,(2002) , 10.1016/S0092-8674(02)00741-9
B. Rost, C. Sander, Improved prediction of protein secondary structure by use of sequence profiles and neural networks Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 7558- 7562 ,(1993) , 10.1073/PNAS.90.16.7558
A. P. Kornev, N. M. Haste, S. S. Taylor, L. F. Ten Eyck, Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 17783- 17788 ,(2006) , 10.1073/PNAS.0607656103
Erica L. Carpenter, Yael P. Mossé, Targeting ALK in neuroblastoma--preclinical and clinical advancements. Nature Reviews Clinical Oncology. ,vol. 9, pp. 391- 399 ,(2012) , 10.1038/NRCLINONC.2012.72
Yaël P Mossé, Marci Laudenslager, Luca Longo, Kristina A Cole, Andrew Wood, Edward F Attiyeh, Michael J Laquaglia, Rachel Sennett, Jill E Lynch, Patrizia Perri, Geneviève Laureys, Frank Speleman, Cecilia Kim, Cuiping Hou, Hakon Hakonarson, Ali Torkamani, Nicholas J Schork, Garrett M Brodeur, Gian P Tonini, Eric Rappaport, Marcella Devoto, John M Maris, None, Identification of ALK as a major familial neuroblastoma predisposition gene Nature. ,vol. 455, pp. 930- 935 ,(2008) , 10.1038/NATURE07261